Login

Join for Free!
16757 members
table of contents table of contents

Biology Articles » Immunobiology » Cord blood in regenerative medicine: do we need immune suppression? » Table

Table
- Cord blood in regenerative medicine: do we need immune suppression?

Table 1
Non-Malignant Disorders Treated With Cord Blood
Disorder
Number Treated
Outcome
Ref.
Hurler's syndrome
20
17 of the 20 children were alive a median of 905 days after transplantation, with complete donor chimerism and normal peripheral-blood alpha-L-iduronidase activity
[100]
Duchenne muscular dystrophy
1
On 42nd day, physical examination revealed obviously improvement in walking, turning the body over, and standing up
[101]
Malignant infantile osteopetrosis
1
Normalization of spine bone mineral density.
[102]
Rothmund-Thomson syndrome
1
Complete immune reconstitution
[55]
Buerger's disease
4
Ischemic rest pain suddenly disappeared. Digital capillaries were increased in number and size.
[84]
Spinal Cord Injury
1
Improved sensory perception and movement in the SPI patient's hips and thighs within 41 days of cell transplantation. Regeneration of the spinal cord at the injured site
[85]
Krabbe's disease
25
Progressive central myelination and continued gains in developmental skills, and most had age-appropriate cognitive function and receptive language skills in patient subset
[14]
Omenn syndrome
1
T cell reconstitution
[103]
Non-healing wounds
2
Accelerated healing
[86]
Refractory anemia
3
All patients are alive and free of disease at between 17 and 39 months after cord blood administration
[104]
Diamond-Blackfan anemia
1
Successful seroconversion to vaccines (diphtheria, pertussis, tetanus, rubella, measles, and BCG) administered 22–34 months post-transplant.
[105]
Severe chronic active Epstein-Barr virus
1
Complete remission without circulating EBV-DNA has continued for 15 months transplant.
[106]
Behcet's disease
1
Twenty-three months after CBT, the patient is doing well and has no signs or symptoms of Behcet's disease
[9]
Mucopolysaccharidosis type IIB (Hunter syndrome)
1
Two years after transplant approximately 55% normal plasma iduronate sulfatase. activity has been restored and abnormal urinary excretion of glycosaminoglycans has nearly completely resolved.
[107]

rating: 9.00 from 2 votes | updated on: 8 Aug 2007 | views: 798 |

Rate article:







excellent!bad…